|Event Name||DIA 2013: Current Complexities and Controversies in Pharmacovigilance, Signal, and Risk Management
Sunday, January 13, 2013
Wednesday, January 16, 2013
Renaissance Washington D.C. Downtown Hotel, 999 Ninth Street
NW Washington, DC,
NW Washington, DC
|Description||This global three-day program will provide new insights into the current issues and associated challenges impacting drug safety, focusing primarily on drug products and biologics, throughout all phases of development and marketed use. Top pharmaceutical, biotech and regulatory representatives who are experts in their field will discuss new and updated legislation in various ICH regions, current regulatory framework for pharmacovigilance in global regions, operational challenges of implementing global benefit-risk analyses and risk management plans, the impact of social media, and the role of epidemiology in safety analysis.